A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut Bergonie
Bordeaux, France
Not, yet, recruiting - Centre Georges François Leclerc
Dijon, France
Not, yet, recruiting - Centre Leon Berard
Lyon, France
Not, yet, recruiting - Gustave Roussy Cancer Campus
Paris, France
Not, yet, recruiting
- Samsung Medical Center
Seoul, South Korea
Joon Oh Park, MD, PhDRecruiting - Seoul National University Hospital
Seoul, South Korea
Do-Youn Oh, MD, PhDRecruiting
- Start Barcelona-Hospital Hm Nou Delfos
Barcelona, Spain
Not, yet, recruiting - Hospital Universitario Fundación Jiménez Díaz- Start Madrid
Madrid, Spain
Not, yet, recruiting - Hospital Universitario Hm Sanchinarro-Start Madrid-Ciocc
Madrid, Spain
Not, yet, recruiting
- Sarah Cannon Research Institute Uk
London, United Kingdom
Not, yet, recruiting - University College Hospital (nihr Uclh Clinical Research Facility)
London, United Kingdom
Not, yet, recruiting - the Christie Nhs Foundation
Manchester, United Kingdom
Not, yet, recruiting
- Mayo Clinic
Phoenix, Arizona, United States
Not, yet, recruiting - Mayo Clinic
Jacksonville, Florida, United States
Not, yet, recruiting - Moffitt Cancer Center
Tampa, Florida, United States
Richard Kim, MDRecruiting - University of Chicago Medical Center
Chicago, Illinois, United States
Not, yet, recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Andreas Varkaris, MD, PhDRecruiting - Mayo Clinic
Rochester, Minnesota, United States
Not, yet, recruiting - the University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
Jordi Rodon Ahnert, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jun 2026
- Primary completion
- 30 Sept 2027
- Completion
- 31 Dec 2028
- Last update posted
- 22 Jun 2026
- Registered enrollment
- 30
- Registry id
- NCT07359820
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.